Recon: FDA approves GSK hepatitis B drug; EQT to buy molecular testing firm Qiagen for $10.8B
Recon: FDA approves GSK hepatitis B drug; EQT to buy molecular testing firm Qiagen for $10.8B RAPS
阅读来源： raps.org全球医药资讯
审批、交易、供应与监管。
FDA Grants Ultomiris Accelerated Approval in the U.S.
FDA Grants Ultomiris Accelerated Approval in the U.S. | PharmExec Pharmaceutical Executive
阅读来源： pharmexec.com
Alcon and OpenAI make acquisitions; Tezspire's latest Phase 3 win
Alcon acquires Neurotech: The Swiss eye specialist paid $550 million upfront to acquire Neurotech Pharmaceuticals and could make additional payments if certain milestones are met. Alcon gains hold of an FDA-approved ...
阅读来源： endpoints.news中国动态
来自中国的制剂与原料药资讯
制剂成品与原料药。
ProBio Successfully Completes NMPA Pre-Approval Inspection for Biologics Manufacturing Facility in Nanjing, China
ProBio Successfully Completes NMPA Pre-Approval Inspection for Biologics Manufacturing Facility in Nanjing, China PR Newswire
阅读来源： prnewswire.com
ESTEVE CDMO Invests More Than $80 Million In New China Manufacturing Site
ESTEVE CDMO Invests More Than $80 Million In New China Manufacturing Site Pulse 2.0
阅读来源： pulse2.com
Egypt and China explore new pharmaceutical manufacturing and technology partnerships
Egypt and China explore new pharmaceutical manufacturing and technology partnerships Fast Company Middle East
阅读来源： fastcompanyme.com每日清晨更新。标题、摘要和图片归所列出版方所有；内容选择不代表 Hanpars 的观点。 我们自己的文章见洞察存档。
电话+98 21 8888 3325 · 办公时间 09:00–17:00（德黑兰时间）
办公室Haniya Parsan Darou，伊朗德黑兰非洲大道扎法尔街 326 号 3 层，邮编 1968734974